Literature DB >> 3282732

Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.

K O Stenger1, F Windler, H Karch, H von Wulffen, J Heesemann.   

Abstract

A case of hemolytic-uremic syndrome (HUS) associated with an infection by a verotoxin-producing Escherichia coli (VTEC), serotype 0111:NM, in a 22-year-old woman who had been on oral contraceptives is presented. VTEC-associated cases of HUS infected by E. coli 0111 have been reported before, but never in adults. The kinetics of the humoral immune response to verotoxin in the patient is observed over three months and described for the first time. The possible role of contraceptives that have been incriminated in the etiology of HUS before is discussed as well. Possible benefits of therapeutical interventions such as hemodialysis, therapeutic plasma exchange, converting enzyme inhibitors, or antibiotics still need clarification. However, it is strongly suggested to include tests for VTEC in the work-up of patients suffering from HUS.

Entities:  

Keywords:  Biology; Case Studies; Contraception; Contraceptive Methods--side effects; Demographic Factors; Developed Countries; Diseases; Europe; Family Planning; Germany, Federal Republic Of; Hematological Effects; Hemic System; Hypertension; Infections; Longterm Effects; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Physiology; Population; Population Dynamics; Research Methodology; Signs And Symptoms; Studies; Time Factors; Vascular Diseases; Western Europe

Mesh:

Substances:

Year:  1988        PMID: 3282732

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Detection and characterization of fecal verotoxin-producing Escherichia coli from healthy cattle.

Authors:  M A Montenegro; M Bülte; T Trumpf; S Aleksić; G Reuter; E Bulling; R Helmuth
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects.

Authors:  J S Greatorex; G M Thorne
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

Review 3.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.